Recombinant Activated Factor VII: The Controversial Conundrum Regarding Its Off-Label Use

被引：14
|
作者：
Karkouti, Keyvan [1 ]
Levy, Jerrold H. [2 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Dept Anesthesiol & Hlth Policy Management & Evalu, Toronto, ON M5G 2C4, Canada
[2] Emory Univ, Dept Anesthesiol, Sch Med Cardiothorac Anesthesiol & Crit Care Emor, Atlanta, GA 30322 USA
来源：
ANESTHESIA AND ANALGESIA | 2011年 / 113卷 / 04期
关键词：
CARDIAC-SURGERY; HEALTHY-SUBJECTS; REVERSAL; WARFARIN; SAFETY; RFVIIA;
D O I：
10.1213/ANE.0b013e318228c6a9
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [31] Off-license use of recombinant activated factor VII
    Ghorashian, S
    Hunt, BJ
    BLOOD REVIEWS, 2004, 18 (04) : 245 - 259
  • [32] The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?
    Altman R.
    Scazziota A.
    de Lourdes Herrera M.
    Gonzalez C.D.
    Thrombosis Journal, 8 (1)
  • [33] Off-label use of intravitreal bevacizumab: A global conundrum
    Singh, Samya
    Saxena, Sandeep
    Akduman, Levent
    Meyer, Carsten H.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (05) : 617 - 619
  • [34] Off-label use of recombinant factor VIIa (rFVIIa) for postoperative hematuria in a factor VII deficient renal transplant patient.
    Gloster, E
    Strauss, R
    DaCosta, M
    Essex, D
    Distant, D
    Braverman, A
    BLOOD, 2000, 96 (11) : 82B - 83B
  • [35] RECOMBINANT ACTIVATED FACTOR VIIA IN CARDIAC SURGERY: REVIEW OF THE OFF-LABEL USE IN A DUTCH GENERAL HOSPITAL
    Kieft, Hans
    Geurts, Mannes
    Jansman, Frank
    Ziekenhuis, Deventer
    Spanjersberg, Sander
    Hospes, Wobbe
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A406 - A406
  • [36] Research on patient safety for off-label use of recombinant factor VIIa
    Aysola, Agnes E.
    Wahi, Monika M.
    McKelvey, Russell P.
    Gerdik, Cynthia Russell
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (08) : 600 - +
  • [37] Topical questions regarding off-label use
    Dierks, C
    Nitz, G
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2003, 128 (41) : 2138 - 2142
  • [38] Off-label use of recombinant activated factor vii in intractable haemorrhage after cardiovascular surgery: an observational study of french practices (2005-2007)
    Hacquard, M.
    Durand, M.
    Lecompte, T.
    Carteaux, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 864 - 864
  • [39] Use of recombinant activated factor VII
    Reingardiene, Dagmara
    Lazauskas, Robertas
    MEDICINA-LITHUANIA, 2009, 45 (03): : 248 - 253
  • [40] Off-label use of recombinant factor VIIa in two tertiary hospitals in Queensland
    Donovan, Peter J.
    Iedema, Joel
    McLeod, Donald S.
    Kubler, Paul
    Pillans, Peter
    ANZ JOURNAL OF SURGERY, 2013, 83 (03) : 149 - 154
12345